Home Healthcare Animal Health Veterinary Oncology Market

Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Surgery, Radiology, Chemotherapy, Immunotherapy, Targeted Therapy, Others), By Animal Type (Canine, Feline, Others), By Cancer Type (Lymphoma, Mast Cell Cancer, Mammary and Squamous Cell Cancer, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR911DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Veterinary Oncology Market, By Therapy 2022-2034 (USD MILLION/ Units)
    1. Surgery
    2. Radiology
    3. Chemotherapy
    4. Immunotherapy
    5. Targeted Therapy
    6. Others
  2. Veterinary Oncology Market, By Animal Type 2022-2034 (USD MILLION/ Units)
    1. Canine
    2. Feline
    3. Others
  3. Veterinary Oncology Market, By Cancer Type 2022-2034 (USD MILLION/ Units)
    1. Lymphoma
    2. Mast Cell Cancer
    3. Mammary and Squamous Cell Cancer
    4. Others
  4. Regional Veterinary Oncology Market
    1. North America
      1. North America Veterinary Oncology Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
      2. North America Veterinary Oncology Market By Animal Type 2022-2034 (USD MILLION/ Units)
        1. Canine
        2. Feline
        3. Others
      3. North America Veterinary Oncology Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lymphoma
        2. Mast Cell Cancer
        3. Mammary and Squamous Cell Cancer
        4. Others
      4. U.S.
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      5. Canada
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
    2. Europe
      1. Europe Veterinary Oncology Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
      2. Europe Veterinary Oncology Market By Animal Type 2022-2034 (USD MILLION/ Units)
        1. Canine
        2. Feline
        3. Others
      3. Europe Veterinary Oncology Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lymphoma
        2. Mast Cell Cancer
        3. Mammary and Squamous Cell Cancer
        4. Others
      4. U.K.
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      5. Germany
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      6. France
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      7. Spain
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      8. Italy
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      9. Russia
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      10. Nordic
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      11. Benelux
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      12. Rest of Europe
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
    3. APAC
      1. APAC Veterinary Oncology Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
      2. APAC Veterinary Oncology Market By Animal Type 2022-2034 (USD MILLION/ Units)
        1. Canine
        2. Feline
        3. Others
      3. APAC Veterinary Oncology Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lymphoma
        2. Mast Cell Cancer
        3. Mammary and Squamous Cell Cancer
        4. Others
      4. China
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      5. Korea
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      6. Japan
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      7. India
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      8. Australia
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      9. Taiwan
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      10. South East Asia
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      11. Rest of Asia-Pacific
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
    4. Middle East and Africa
      1. Middle East and Africa Veterinary Oncology Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
      2. Middle East and Africa Veterinary Oncology Market By Animal Type 2022-2034 (USD MILLION/ Units)
        1. Canine
        2. Feline
        3. Others
      3. Middle East and Africa Veterinary Oncology Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lymphoma
        2. Mast Cell Cancer
        3. Mammary and Squamous Cell Cancer
        4. Others
      4. UAE
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      5. Turkey
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      6. Saudi Arabia
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      7. South Africa
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      8. Egypt
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      9. Nigeria
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      10. Rest of MEA
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
    5. LATAM
      1. LATAM Veterinary Oncology Market By Therapy 2022-2034 (USD MILLION/ Units)
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
      2. LATAM Veterinary Oncology Market By Animal Type 2022-2034 (USD MILLION/ Units)
        1. Canine
        2. Feline
        3. Others
      3. LATAM Veterinary Oncology Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Lymphoma
        2. Mast Cell Cancer
        3. Mammary and Squamous Cell Cancer
        4. Others
      4. Brazil
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      5. Mexico
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      6. Argentina
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      7. Chile
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      8. Colombia
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
      9. Rest of LATAM
        1. Surgery
        2. Radiology
        3. Chemotherapy
        4. Immunotherapy
        5. Targeted Therapy
        6. Others
        7. Canine
        8. Feline
        9. Others
        10. Lymphoma
        11. Mast Cell Cancer
        12. Mammary and Squamous Cell Cancer
        13. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.